Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 233-235

  Pfaller, M A ^a   Messer, S ^a   Jones, R N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 [4 [4 [[5 (2,4 DIFLUOROPHENYL)TETRAHYDRO 5 (1H 1,2,4 TRIAZOL 1 YLMETHYL)FURAN 3 YL]METHOXY]PHENYL] 1 PIPERAZINYL] PHENYL] 2,4 DIHYDRO 2 (1 ETHYL 2 HYDROXYPROPYL) 3H 1,2,4 TRIAZOLE 3 ONE; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

EID: 0031054149     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.233     Document Type: Article

References (13)

1. Cacciapuoti, A., R. Parmegiani, D. Loebenberg, B. Antonacci, E. L. Moss, Jr., F. Menzel, Jr., C. Norris, M. Michalski, R. S. Hare, and G. H. Miller. 1995. Efficacy of Sch 56592 in pulmonary aspergillosis and systemic candidiasis in mice, abstr. F66, p. 124. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Galgiani, J. N., and M. L. Lewis. 1997. In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob. Agents Chemother. 41:180-183.
3. Girijavallabhan, V. M., A. K. Saksena, R. G. Lovey, F. Bennett, R. E. Pike, H. Wang, P. Pinto, Y. T. Liu, N. Patel, and A. K. Ganguly. 1995. Sch 56592, a novel broad spectrum antifungal agent, abstr. F61, p. 123. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Wayne, Pa.
5. Nomeir, A., P. Kumari, M. J. Hilbert, D. Loebenberg, A. Cacciapuoti, F. Menzel, Jr., E. Moss, Jr., R. Hare, G. H. Miller, M. N. Cayen, and C. C. Lin. 1995. Comparative pharmacokinetics of a new triazole antifungal agent, Sch 56592, in mice, rats, rabbits, dogs, and cynomolgus monkeys, abstr. F68, p. 124. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Parmegiani, R., A. Cacciapuoti, D. Loebenberg, B. Antonacci, C. Norris, T. Yarosh-Tomaine, M. Michalski, R. S. Hare, and G. H. Miller. 1995. Efficacy of Sch 56592 in experimental vaginal and superficial fungal infections, abstr. F67, p. 124. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Parmegiani, R., A. Cacciapuoti, D. Loebenberg, B. Antonacci, C. Norris, T. Yarosh-Tomaine, M. Michalski, R. S. Hare, and G. H. Miller. 1995. In vitro activity of Sch 56592, an orally active broad-spectrum antifungal agent, abstr. F62, p. 123. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Perfect, J. R., G. M. Cox, R. K. Dodge, and W. A. Schell. 1996. In vitro and in vivo efficacies of the azole Sch 56592, against Cryptococcus neoformans. Antimicrob. Agents Chemother. 40:1910-1913.
9. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, M. G. Rinaldi, C. R. Cooper, and M. R. McGinnis. 1995. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and 5-fluorocytosine. J. Clin. Microbiol. 33:1104-1107.
10. Rex, J. H., M. A. Pfaller, M. Lancaster, F. C. Odds, A. Bolmstrom, and M. G. Rinaldi. 1996. Quality control guidelines for National Committee for Clinical Laboratory Standards-recommended broth macrodilution testing of ketoconazole and itraconazole. J. Clin. Microbiol. 34:816-817.
11. Saksena, A. K., V. M. Girijavallabhan, R. G. Lovey, F. Bennett, R. E. Pike, H. Wang, P. Pinto, Y. T. Liu, N. Patel, and A. K. Ganguly. 1995. Novel analogs of Sch 51048: synthesis and preliminary structure activity relationships, abstr. F83, p. 127. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
12. Sugar, A. M., and X. P. Liu. 1996. In vitro and in vivo activity of Sch 56592 against Blastomyces dermatitidis. Antimicrob. Agents Chemother. 40:1314.
13. Warren, N. G., and K. C. Hazen. 1995. Candida, Cryptococcus, and other yeasts of medical importance, p. 723-737. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.